Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.20 is 152% below its 4-year average of -0.48, near the low end of its 4-year range (-1.20–-0.15).
32.60% below its 12-month average of -0.91.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.33.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 11 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.20
EARNINGS PER SHARE (EPS) AVG TTM
-0.91
EARNINGS PER SHARE (EPS) AVG 3Y
-0.56
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-32.60%
CURRENT VS 3Y AVG
-115.25%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
eXoZymes, Inc.
Market Cap
$51.51M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
N/A
Market Cap
$50.93M
Earnings Per Share (EPS)
N/A
TTM Avg
-7.29
3Y Avg
-67.66
5Y Avg
-178.24
Market Cap
$52.46M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$50.66M
Earnings Per Share (EPS)
-1.49
TTM Avg
-1.25
3Y Avg
-158.58
5Y Avg
-880.75
Market Cap
$52.54M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.75
3Y Avg
-0.80
5Y Avg
-0.90
Market Cap
$52.60M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.08
3Y Avg
0.02
5Y Avg
0.04
Market Cap
$51.72M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$52.78M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.43
3Y Avg
-2.38
5Y Avg
-2.90
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| eXoZymes, Inc. (EXOZ) | $51.51M | -1.20 | -0.91 | -0.56 | N/A |
| biote Corp. (BTMD)vs › | $51.83M | 0.12 | 0.48 | 0.24 | 1.52 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.93M | N/A | -7.29 | -67.66 | -178.24 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | -8.95 | -8.42 | -12.89 | -25.33 |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.66M | -1.49 | -1.25 | -158.58 | -880.75 |
| Aldeyra The (ALDX)vs › | $52.54M | -0.39 | -0.75 | -0.80 | -0.90 |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | N/A | -0.08 | 0.02 | 0.04 |
| Envoy Medical, Inc. (COCH)vs › | $51.72M | -0.67 | -1.36 | -1.71 | -1.31 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.78M | -1.00 | -1.43 | -2.38 | -2.90 |
| Clene Inc. (CLNN)vs › | $50.86M | -3.55 | -4.16 | -5.92 | -5.28 |
Trailing EPS (TTM)
$-1.20
Forward EPS (Est.)
$-1.19
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.09 |
| 2024-12-31 | -0.72 |
| 2023-12-31 | -0.25 |
| 2022-12-31 | -0.17 |
| 2021-12-31 | -0.15 |
